It reflects a shift in the body overall inflammatory state that affects appearance from head to toe
Tirzepatide is generally studied as a dual GIP and GLP-1 receptor agonist, while Retatrutide is studied as a triple receptor agonist involving GIP, GLP-1, and glucagon receptor pathways
COMPREHENSIVE 6-IN-1 SUPPORT FOR MODERN WEIGHT MANAGEMENT*: Supports GLP-1 activity, blood glucose, appetite, metabolism, gut health, and immune function-all in one streamlined formula.* Designed for those pursuing weight loss, enhancing GLP-1 activity naturally, complementing GLP-1 medications, or seeking a non-drug alternative, with an easy-to-integrate daily capsule routine
Is that a typical length of time that someone might use a GLP-1
Most commercial insurance plans that cover GLP-1 for weight loss require prior authorization documenting: BMI at or above 30 (or 27 with a weight-related condition like hypertension, type 2 diabetes, dyslipidemia, or sleep apnea), and in some cases, documented prior attempts at lifestyle modification
This explains why weight loss with retatrutide dose escalation to 12mg exceeds what appetite suppression alone can account for